Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
Site- and Paralog-specific mapping of the human small-ubiquitin modifier (SUMO) proteome
EF 2017-18
Résumé
SUMOylation is the addition of a small ubiquitin-like modifier (SUMO) protein to a target substrate protein. It is an essential post-translational modification (PTM) that is involved in the regulation of many key cellular processes. While the overall function of SUMO has been studied, it is unclear the role that different forms, or paralogs of SUMO have in vertebrates. The proposed research will aim to identify the specific protein targets, acceptor sites and functions in which SUMO paralogs have. The method developed to answer these questions involves a series of purification and enrichment steps of protein modified by SUMO. These enriched proteins/peptides will be put through large-scale proteome analyses using LC-MS/MS on a Q-Exactive HF mass spectrometer. Using HEK293 as a base cell-line, we have genetically modified SUMO genes allowing us to better manipulate the corresponding protein in ways that cannot be done with normal/wild-type SUMO. These modifications make it easier for identification of target protein substrates and the exact sites that SUMO bind to. To increase global SUMOylation to identifiable levels, we will treat HEK293 cells with a proteasome inhibitor (MG132) and/or heatshock. This project will provide important tools to understand the regulation of protein SUMOylation, a biological process of importance given that several genes of the SUMO pathway are deregulated in cancer. With knowledge gained from the proposed experiment, it's possible that potential novel cancer therapeutic targets could be determined.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386385
Name
Nelson Trent G
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Site- and Paralog-specific mapping of the human small-ubiquitin modifier (SUMO) proteome
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Characterization; Large-Scale Analysis; Post-Transnational Modification
Abstract
SUMOylation is the addition of a small ubiquitin-like modifier (SUMO) protein to a target substrate protein. It is an essential post-translational modification (PTM) that is involved in the regulation of many key cellular processes. While the overall function of SUMO has been studied, it is unclear the role that different forms, or paralogs of SUMO have in vertebrates. The proposed research will aim to identify the specific protein targets, acceptor sites and functions in which SUMO paralogs have. The method developed to answer these questions involves a series of purification and enrichment steps of protein modified by SUMO. These enriched proteins/peptides will be put through large-scale proteome analyses using LC-MS/MS on a Q-Exactive HF mass spectrometer. Using HEK293 as a base cell-line, we have genetically modified SUMO genes allowing us to better manipulate the corresponding protein in ways that cannot be done with normal/wild-type SUMO. These modifications make it easier for identification of target protein substrates and the exact sites that SUMO bind to. To increase global SUMOylation to identifiable levels, we will treat HEK293 cells with a proteasome inhibitor (MG132) and/or heatshock. This project will provide important tools to understand the regulation of protein SUMOylation, a biological process of importance given that several genes of the SUMO pathway are deregulated in cancer. With knowledge gained from the proposed experiment, it's possible that potential novel cancer therapeutic targets could be determined.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nelson, Trent G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~